Your browser doesn't support javascript.
loading
Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance.
Barone, Giuseppe; Barry, Ailish; Bautista, Francisco; Brichard, Bénédicte; Defachelles, Anne-Sophie; Herd, Fiona; Manzitti, Carla; Reinhardt, Dirk; Rubio, Pedro M; Wieczorek, Aleksandra; van Noesel, Max M.
Afiliação
  • Barone G; Department of Paediatric Oncology, Great Ormond Street Hospital for Children, London, UK.
  • Barry A; Department of Paediatric Oncology, Great Ormond Street Hospital for Children, London, UK.
  • Bautista F; Department of Paediatric Haematology and Oncology, Hospital Universitario Niño Jesus, Madrid, Spain.
  • Brichard B; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • Defachelles AS; Pediatric and AYA Oncology Unit, Centre Oscar-Lambret, Lille Cedex, France.
  • Herd F; Department of Paediatric Oncology, Royal Aberdeen Children's Hospital, Aberdeen, UK.
  • Manzitti C; Oncology Unit, Istituto Giannina Gaslini, Genova, Italy.
  • Reinhardt D; Pediatrics III, Pediatric Hematology/Oncology, University Hospital Essen, Essen, Germany.
  • Rubio PM; Pediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Wieczorek A; Pediatric Oncology-Hematology Department, Institute of Pediatrics, Jagiellonian University Medical College, Kraków, Poland.
  • van Noesel MM; Department of Solid Tumors, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. M.M.vanNoesel@prinsesmaximacentrum.nl.
Paediatr Drugs ; 23(6): 537-548, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34541620

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neuroblastoma Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Neuroblastoma Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article